ASCITES DERIVED PRIMARY PANCREATIC DUCTAL ADENOCARCINOMA CELL CULTURES FROM DIFFERENT PATIENTS AS A PLATFORM FOR PERSONALIZED MEDICINE

被引：0
|
作者：
Golan, T. [1 ]
Atias, D. [1 ]
Barshack, I. [1 ]
Avivi, C. [1 ]
Goldstein, R. S. [2 ]
Berger, R. [1 ]
机构：
[1] Sheba Med Ctr, Ramat Gan, Israel
[2] Innovo Mimemt, Jerusalem, Israel
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [41] The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma
    Ling, Qi
    Xu, Xiao
    Ye, Panpan
    Xie, Haiyang
    Gao, Feng
    Hu, Qichao
    Liu, Zhikun
    Wei, Xuyong
    Roeder, Christian
    Trauzold, Anna
    Kalthoff, Holger
    Zheng, Shusen
    ONCOTARGET, 2017, 8 (09) : 15159 - 15167
  • [42] Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models
    Fenu, Grazia
    Grinan-Lison, Carmen
    Pisano, Andrea
    Gonzalez-Titos, Aitor
    Farace, Cristiano
    Fiorito, Giovanni
    Etzi, Federica
    Perra, Teresa
    Sabalic, Angela
    Toledo, Belen
    Peran, Macarena
    Solinas, Maria Giuliana
    Porcu, Alberto
    Marchal, Juan Antonio
    Madeddu, Roberto
    BMC CANCER, 2024, 24 (01)
  • [43] Resolution of Diabetes After Pancreaticoduodenectomy in Patients with and without Pancreatic Ductal Cell Adenocarcinoma
    Wu, Jin-Ming
    Kuo, Ting-Chun
    Yang, Ching-Yao
    Chiang, Pin-Yi
    Jeng, Yung-Ming
    Huang, Pei-Hsin
    Tien, Yu-Wen
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (01) : 242 - 249
  • [44] A novel high-throughput microfluidic drug screening platform using pancreatic ductal adenocarcinoma derived organoids
    Kramer, Bart
    van Paassen, Wijnand
    de Haan, Luuk
    Lanz, Henriette
    Joore, Jos
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Enhanced epithelial and mesenchymal features of pancreatic ductal adenocarcinoma cell lines in 3-dimensional cultures
    Ishiwata, Toshiyuki
    Shichi, Yuuki
    Gomi, Fujiya
    Nonaka, Keisuke
    Sasaki, Norihiko
    Toyoda, Masashi
    Takahashi, Kimimasa
    Arai, Tomio
    CANCER SCIENCE, 2023, 114 : 2121 - 2121
  • [46] A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts
    Beer, Meike
    Kuppalu, Nirmala
    Stefanini, Matteo
    Becker, Holger
    Schulz, Ingo
    Manoli, Sagar
    Schuette, Julia
    Schmees, Christian
    Casazza, Armando
    Stelzle, Martin
    Arcangeli, Annarosa
    SCIENTIFIC REPORTS, 2017, 7
  • [47] A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts
    Meike Beer
    Nirmala Kuppalu
    Matteo Stefanini
    Holger Becker
    Ingo Schulz
    Sagar Manoli
    Julia Schuette
    Christian Schmees
    Armando Casazza
    Martin Stelzle
    Annarosa Arcangeli
    Scientific Reports, 7
  • [48] Clinical features of patients with pancreatic ductal adenocarcinoma with a history of other primary malignancies: A retrospective analysis
    Hayashi, Hironori
    Amaya, Koji
    Tokoro, Tomokazu
    Mori, Kosuke
    Takenaka, Shunsuke
    Sugimoto, Yuya
    Kitano, Yuto
    Kurata, Toru
    Kawai, Shunsuke
    Hirose, Atsushi
    Tsukada, Tomoya
    Kaji, Masahide
    Shimizu, Koichi
    Maeda, Kiichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (03)
  • [49] The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma
    Jamieson, Nigel B.
    Mohamed, Mohamed
    Oien, Karin A.
    Foulis, Alan K.
    Dickson, Euan J.
    Imrie, Clem W.
    Carter, C. Ross
    McKay, Colin J.
    McMillan, Donald C.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) : 3581 - 3590
  • [50] Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma
    Khan, Imteyaz Ahmad
    Singh, Nidhi
    Gunjan, Deepak
    Gopi, Srikant
    Dash, Nihar Ranjan
    Gupta, Surabhi
    Saraya, Anoop
    IMMUNOGENETICS, 2023, 75 (05) : 433 - 443
12345